ArticleScience advances2025

Small molecule OPA1 inhibitors amplify cytochrome c release and reverse cancer cells resistance to Bcl-2 inhibitors.

Anna Pellattiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.